Quidel | QDEL - Operating Profit

Stock Price
10.32
Daily Change
-1.07 -9.39%
Monthly
-18.64%
Yearly
-69.16%
Q2 Forecast
10.11

Quidel reported $-31.8M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Abbott USD 1.85B 399M Mar/2026
Agilent USD 353M 90M Dec/2025
Avanos Medical USD 8.9M 15.87M Mar/2026
Becton, Dickinson and Co. USD 627M 36M Mar/2026
Bruker USD 10.2M 66.1M Mar/2026
Cerus USD -1.45M 488K Dec/2024
Charles River Laboratories USD 119.9M 44.08M Mar/2026
Danaher USD 1.34B 158M Mar/2026
Haemonetics USD 67.4M 8.9M Dec/2025
Illumina USD 239M 17M Mar/2026
IQVIA Holdings USD 565M 2.11B Mar/2026
Merit Medical Systems USD 44.16M 10.04M Mar/2026
Mettler Toledo International USD 233.93M 118M Mar/2026
Myriad Genetics USD -3M 20.3M Dec/2025
Neogen USD -3.3M 2.08M Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Pacific Biosciences Of California USD -53.19M 35.08M Dec/2025
Quidel USD -31.8M 5.5M Mar/2026
Revvity USD 82.77M 63.06M Mar/2026
STAAR Surgical USD 17.4M 28.34M Mar/2026
Thermo Fisher Scientific USD 1.91B 389M Mar/2026
Waters USD 148M 122.52M Mar/2026